These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 36744556)

  • 1. Animal Models for the Study of Neurologic Manifestations Of COVID-19.
    Carpenter KC; Yang J; Xu JJ
    Comp Med; 2023 Feb; 73(1):91-103. PubMed ID: 36744556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central nervous system outcomes of COVID-19.
    Doyle MF
    Transl Res; 2022 Mar; 241():41-51. PubMed ID: 34601116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural and genetically-modified animal models to investigate pulmonary and extrapulmonary manifestations of COVID-19.
    Tiwari S; Goel G; Kumar A
    Int Rev Immunol; 2024; 43(1):13-32. PubMed ID: 35757923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurologic Manifestations and Complications of COVID-19.
    Hensley MK; Markantone D; Prescott HC
    Annu Rev Med; 2022 Jan; 73():113-127. PubMed ID: 34416121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 and neurologic manifestations: a synthesis from the child neurologist's corner.
    Valderas C; Méndez G; Echeverría A; Suarez N; Julio K; Sandoval F
    World J Pediatr; 2022 Jun; 18(6):373-382. PubMed ID: 35476245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic Approaches to the Neurologic Manifestations of COVID-19.
    Graham EL; Koralnik IJ; Liotta EM
    Neurotherapeutics; 2022 Sep; 19(5):1435-1466. PubMed ID: 35861926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19).
    Harapan BN; Yoo HJ
    J Neurol; 2021 Sep; 268(9):3059-3071. PubMed ID: 33486564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute Neurologic Manifestations of Respiratory Viruses.
    Pizzi MA
    Continuum (Minneap Minn); 2021 Oct; 27(5):1365-1381. PubMed ID: 34618764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurologic complications of coronavirus and other respiratory viral infections.
    Cavallieri F; Sellner J; Zedde M; Moro E
    Handb Clin Neurol; 2022; 189():331-358. PubMed ID: 36031313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges and management of neurological and psychiatric manifestations in SARS-CoV-2 (COVID-19) patients.
    Orsini A; Corsi M; Santangelo A; Riva A; Peroni D; Foiadelli T; Savasta S; Striano P
    Neurol Sci; 2020 Sep; 41(9):2353-2366. PubMed ID: 32767055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurological Involvement in COVID-19 and Potential Mechanisms: A Review.
    Aghagoli G; Gallo Marin B; Katchur NJ; Chaves-Sell F; Asaad WF; Murphy SA
    Neurocrit Care; 2021 Jun; 34(3):1062-1071. PubMed ID: 32661794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 Infection Leads to Neurological Dysfunction.
    Acharya A; Kevadiya BD; Gendelman HE; Byrareddy SN
    J Neuroimmune Pharmacol; 2020 Jun; 15(2):167-173. PubMed ID: 32447746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central Nervous System Manifestations Associated with COVID-19.
    Divani AA; Andalib S; Biller J; Di Napoli M; Moghimi N; Rubinos CA; Nobleza CO; Sylaja PN; Toledano M; Lattanzi S; McCullough LD; Cruz-Flores S; Torbey M; Azarpazhooh MR
    Curr Neurol Neurosci Rep; 2020 Oct; 20(12):60. PubMed ID: 33128130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of animal models for COVID-19.
    Qi F; Qin C
    Animal Model Exp Med; 2022 Oct; 5(5):401-409. PubMed ID: 36301011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of selected animal models for respiratory coronavirus infection and its application in drug research.
    Qin S; Li R; Zheng Z; Zeng X; Wang Y; Wang X
    J Med Virol; 2022 Jul; 94(7):3032-3042. PubMed ID: 35285034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Animal models to study the neurological manifestations of the post-COVID-19 condition.
    Usai C; Mateu L; Brander C; Vergara-Alert J; Segalés J
    Lab Anim (NY); 2023 Sep; 52(9):202-210. PubMed ID: 37620562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenging Cases in Neurology: Neurologic Complications of COVID-19.
    Horta L; Bakhtyari A; Greige T; Anand P
    Semin Neurol; 2022 Dec; 42(6):708-715. PubMed ID: 36417991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Novel coronavirus infection (COVID-19) and nervous system involvement: pathogenesis, clinical manifestations, organization of neurological care].
    Gusev EI; Martynov MY; Boyko AN; Voznyuk IA; Latsh NY; Sivertseva SA; Spirin NN; Shamalov NA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(6):7-16. PubMed ID: 32678542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding the Role of Blood Vessels in the Neurologic Manifestations of Coronavirus Disease 2019 (COVID-19).
    Whitmore HAB; Kim LA
    Am J Pathol; 2021 Nov; 191(11):1946-1954. PubMed ID: 34126084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What can the neurological manifestations of COVID-19 tell us: a meta-analysis.
    He Y; Bai X; Zhu T; Huang J; Zhang H
    J Transl Med; 2021 Aug; 19(1):363. PubMed ID: 34425827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.